Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation

Gemcitabine and nab-paclitaxel demonstrated similar clinical activity and toxicity compared to previous retrospective reports utilizing gemcitabine and docetaxel in patients with recurrent osteosarcoma. Serial analysis of CTC and ctDNA was feasible in this prospective multi-institution study and provides preliminary data on the use of these assays in patients with relapsed disease.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2024-10-03
DOI
https://doi.org/10.1158/1078-0432.ccr-24-1339
Citations
9
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
3.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation

Jonathan Metts, Brooke L. Fridley, Daniel L. Adams, Eric Sandler et al.
9 citations
Clinical Cancer Research
Sarcoma Diagnosis and Treatment
3.77
article

Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation

Jonathan Metts, Brooke L. Fridley, Daniel L. Adams, Eric Sandler, Emi Caywood, Michael S. Isakoff, Damon R. Reed, Aditi Dhir, David M. Loeb, Masanori Hayashi, Joanne Lagmay, Lars M. Wagner, Avery Bodlak, Javier Oesterheld, Leo Mascarenhas, Christine A. Pratilas, Scott C. Borinstein, José Laborde, Bhuvana A. Setty, Hong Yin, Jun Yin, Matteo Trucco
article en
9 citations

Abstract

Gemcitabine and nab-paclitaxel demonstrated similar clinical activity and toxicity compared to previous retrospective reports utilizing gemcitabine and docetaxel in patients with recurrent osteosarcoma. Serial analysis of CTC and ctDNA was feasible in this prospective multi-institution study and provides preliminary data on the use of these assays in patients with relapsed disease.

Clinical Cancer ResearchVol. 30(23)
Cedars-Sinai Medical Center (US), Albert Einstein College of Medicine (US), Nationwide Children's Hospital (US), Cleveland Clinic (US), Children's Mercy Hospital (US), UF Health Shands Hospital (US), Johns Hopkins University (US), University of Miami (US), Duke University (US), Moffitt Cancer Center (US), Children's Hospital Colorado (US), Johns Hopkins All Children's Hospital (US), Connecticut Children's Medical Center (US), Nemours Children's Health System (US), Center for Cancer and Blood Disorders (US), Creatv MicroTech (United States) (US), Levine Children's Hospital (US), Children's Healthcare of Atlanta (US), Nemours Children's Clinic (US), Sidney Kimmel Comprehensive Cancer Center (US), Vanderbilt University Medical Center (US), University of Colorado Denver (US)
Good health and well-being
Openalex Percentile: Top 6%
Sarcoma Diagnosis and Treatment
3.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.